All Stories

  1. Cationic metal-binding coumarin amphiphiles as membrane-active antimicrobial agents
  2. Microbiome Profiling and Antimicrobial Efficacy of a Novel Silver‐Nanoparticle Hydrogel Dressing Against Clinical Isolates From Paediatric Burn Wounds
  3. A novel self-transmissible mega plasmid from extensively drug-resistant Klebsiella oxytoca carries multiple antimicrobial resistance genes and acts as a resistance reservoir
  4. Cationic metal-binding coumarin amphiphiles as membrane-active antimicrobial agents
  5. Genotypic and Phenotypic Characterization of MRSA Colonization and Persistence in Residential Aged Care Facilities in Adelaide, Australia
  6. The effect of commonly used non-antibiotic medications on antimicrobial resistance development in Escherichia coli
  7. Lacritin cleavage-potentiated targeting of iron - respiratory reciprocity promotes bacterial death
  8. Identification of a Potential High-Risk Clone and Novel Sequence Type of Carbapenem-Resistant Pseudomonas aeruginosa in Metro Manila, Philippines
  9. The continued evolution of the L2 cephalosporinase in Stenotrophomonas maltophilia: a key driver of beta-lactam resistance
  10. Commonly used non-antibiotic medications promote mutation frequency and antimicrobial resistance inEscherichia coli
  11. Enterobacter adelaidei sp. nov. Isolation of an extensively drug resistant strain from hospital wastewater in Australia and the global distribution of the species
  12. Identification of potential high-risk clones of Carbapenem-ResistantPseudomonas aeuroginosaco-producing, KPC-2, VIM-2 and OXA-74 from tertiary hospitals in Metro Manila, Philippines
  13. New antibiotics to combat One Health AMR
  14. Multidrug‐resistant Stenotrophomonas maltophilia in residential aged care facilities: An emerging threat
  15. Resistome Analysis of Klebsiella pneumoniae Complex from Residential Aged Care Facilities Demonstrates Intra-facility Clonal Spread of Multidrug-Resistant Isolates
  16. Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics
  17. Identification and evolution of ICE-PmuST394: a novel integrative conjugative element in Pasteurella multocida ST394
  18. Recommendations of Key Elements within an Integrated Monitoring Framework of Antimicrobial Resistance for Asian Countries
  19. The scope of antimicrobial resistance in residential aged care facilities determined through analysis of Escherichia coli and the total wastewater resistome
  20. Orthogonal Reversed-Phase C18 and Pentafluorophenyl HPLC Separation for Phytochemical Profiling of Serrulatanes in Eremophila denticulata
  21. Combined Structure- and Ligand-Based Approach for the Identification of Inhibitors of AcrAB-TolC in Escherichia coli
  22. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-i...
  23. Genomic profiling of Pasteurella multocida isolated from feedlot cases of bovine respiratory disease
  24. Adding to the family of resistance factors against last resort antibiotics: Identification and characterization of a novel carbapenemase, CIM-1
  25. Design and synthesis of benzochromene derivatives as AcrB inhibitors for the reversal of bacterial multidrug resistance
  26. Polypharmacology-Labeled Molecular Networking: An Analytical Technology Workflow for Accelerated Identification of Multiple Bioactive Constituents in Complex Extracts
  27. Targeting malaria parasites with novel derivatives of azithromycin
  28. In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens
  29. Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division
  30. Antimicrobial susceptibility and genomic analysis of Histophilus somni isolated from cases of bovine respiratory disease in Australian feedlot cattle
  31. Lacritin Bactericidal Peptide N‐104 Targeting of Inner Membrane Transporters FeoB and PotH (SpuG) Individually Absent in N‐104 Resistant Strains of Human Opportunistic Pathogen, P. aeruginosa PA14
  32. Correction: Alhamami et al. First Emergence of Resistance to Macrolides and Tetracycline Identified in Mannheimia haemolytica and Pasteurella multocida Isolates from Beef Feedlots in Australia. Microorganisms 2021, 9, 1322
  33. The Structural and Functional Study of Efflux Pumps Belonging to the RND Transporters Family from Gram-Negative Bacteria
  34. Complete Genome Sequence of Pasteurella multocida Sequence Type 394, Isolated from a Case of Bovine Respiratory Disease in Australia
  35. Impact of a Novel Anticoccidial Analogue on Systemic Staphylococcus aureus Infection in a Bioluminescent Mouse Model
  36. The Wastewater Resistome of Residential Aged Care Facilities Indicates a Role of Antimicrobial Stewardship in Reducing Resistance
  37. Worldwide distribution and environmental origin of the Adelaide imipenemase (AIM-1), a potent carbapenemase in Pseudomonas aeruginosa
  38. Bioactivity-guided isolation of compounds from Sophora flavescens with antibacterial activity against Acinetobacter baumannii
  39. An optimized and robust PEG precipitation method for detection of SARS-CoV-2 in wastewater
  40. Taking AIM-(1) at carbapenem resistance in Pseudomonas aeruginosa
  41. Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci
  42. SdiA, a Quorum-Sensing Regulator, Suppresses Fimbriae Expression, Biofilm Formation, and Quorum-Sensing Signaling Molecules Production in Klebsiella pneumoniae
  43. First Emergence of Resistance to Macrolides and Tetracycline Identified in Mannheimia haemolytica and Pasteurella multocida Isolates from Beef Feedlots in Australia
  44. Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections
  45. Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis
  46. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens
  47. Comparison of Two Transmission Electron Microscopy Methods to Visualize Drug-Induced Alterations of Gram-Negative Bacterial Morphology
  48. Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance
  49. A pH-neutral electrolyzed oxidizing water significantly reduces microbial contamination of fresh spinach leaves
  50. Neutral electrolyzed oxidizing water is effective for pre-harvest decontamination of fresh produce
  51. Catecholic alkaloid sulfonates and aromatic nitro compounds from Portulaca oleracea and screening of their anti-inflammatory and anti-microbial activities
  52. Antimicrobial Action and Reversal of Resistance in MRSA by Difluorobenzamide Derivatives Targeted at FtsZ
  53. Design and synthesis of aryl-substituted pyrrolidone derivatives as quorum sensing inhibitors
  54. Design and synthesis of novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB to reverse the bacterial multidrug resistance
  55. Efflux Pump-Driven Antibiotic and Biocide Cross-Resistance in Pseudomonas aeruginosa Isolated from Different Ecological Niches: A Case Study in the Development of Multidrug Resistance in Environmental Hotspots
  56. In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice
  57. Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors
  58. Comparative antibacterial activities of neutral electrolyzed oxidizing water and other chlorine-based sanitizers
  59. Disinfection options for irrigation water: Reducing the risk of fresh produce contamination with human pathogens
  60. Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance
  61. Allicin prevents the formation of Proteus-induced urinary crystals and the blockage of catheter in a bladder model in vitro
  62. Antimicrobial effects of cinnamon essential oil and cinnamaldehyde combined with EDTA against canine otitis externa pathogens
  63. In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens
  64. Reversing resistance to counter antimicrobial resistance in the World Health Organisation’s critical priority of most dangerous pathogens
  65. Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance
  66. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators
  67. Induction of Escherichia coli into a VBNC state through chlorination/chloramination and differences in characteristics of the bacterium between states
  68. Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing
  69. Genomic characterization of coagulase-negative staphylococci including methicillin-resistant Staphylococcus sciuri causing bovine mastitis
  70. Novel 5-methyl-2-phenylphenanthridium derivatives as FtsZ-targeting antibacterial agents from structural simplification of natural product sanguinarine
  71. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance
  72. Substitution of terminal amide with 1 H -1,2,3-triazole: Identification of unexpected class of potent antibacterial agents
  73. Design, synthesis and biological activity evaluation of novel 4-subtituted 2-naphthamide derivatives as AcrB inhibitors
  74. Efficacy evaluation of a new water sanitizer for increasing the shelf life of Southern Australian King George Whiting and Tasmanian Atlantic Salmon fillets
  75. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent
  76. Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors
  77. Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines
  78. Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria
  79. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition
  80. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance
  81. Synthesis and antibacterial activity of novel 3- O -descladinosylazithromycin derivatives
  82. Bio-augmentation and nutrient amendment decrease concentration of mercury in contaminated soil
  83. Structural model of FeoB, the iron transporter from Pseudomonas aeruginosa, predicts a cysteine lined, GTP-gated pore
  84. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
  85. Synthesis and Biological Evaluation of Novel FtsZ‐targeted 3‐arylalkoxy‐2,6‐difluorobenzamides as Potential Antimicrobial Agents
  86. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition
  87. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump
  88. Expression, purification and functional reconstitution of FeoB, the ferrous iron transporter from Pseudomonas aeruginosa
  89. Structure of the AcrAB–TolC multidrug efflux pump
  90. Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets
  91. Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa
  92. A Multidrug ABC Transporter with a Taste for Salt
  93. Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions
  94. On the energy-dependence of Hoechst 33342 transport by the ABC transporter LmrA
  95. Two Proton Translocation Pathways in a Secondary Active Multidrug Transporter
  96. New light on multidrug binding by an ATP-binding-cassette transporter
  97. Similarities between ATP-dependent and ion-coupled multidrug transporters
  98. Drug-Lipid A Interactions on the Escherichia coli ABC Transporter MsbA
  99. A critical role of a carboxylate in proton conduction by the ATP‐binding cassette multidrug transporter LmrA
  100. Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2)
  101. Reversible Transport by the ATP-binding Cassette Multidrug Export Pump LmrA
  102. Purification and properties of theEscherichia colinucleoside transporter NupG, a paradigm for a major facilitator transporter sub-family
  103. An ABC transporter with a secondary-active multidrug translocator domain
  104. A new dimer interface for an ABC transporter
  105. The ATP Binding Cassette Multidrug Transporter LmrA and Lipid Transporter MsbA Have Overlapping Substrate Specificities
  106. Sterol Transport by the Human Breast Cancer Resistance Protein (ABCG2) Expressed in Lactococcus lactis
  107. Molecular dissection of membrane-transport proteins: mass spectrometry and sequence determination of the galactose‒H+ symport protein, GalP, of Escherichia coli and quantitative assay of the incorporation of [ring-2-13C]histidine and 15NH3
  108. Do mammals make their own morphine?
  109. Expression of prokaryotic membrane transport proteins in Escherichia coli
  110. Purification and Characterization of a Metalloprotease fromChryseobacterium indologenesIx9a and Determination of the Amino Acid Specificity with Electrospray Mass Spectrometry
  111. Equipping a Research Scale Fermentation Laboratory for Production of Membrane Proteins